Portrait: Dr. Paolo Dell’Orto

Dr. Paolo Dell’Orto

Specialist in Urology

Specialty

Specialist in Urology

Area

Surgery

Registration

Milan Medical Board, no. 31471

Languages

Italian, English, French

Since 2026 he has been Director of the Urology Department at Fatebenefratelli e Oftalmico Hospital in Milan (ASST Fatebenefratelli-Sacco). He was previously deputy director of Urology at ASST Santi Paolo e Carlo and, for many years, at Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan.

As lead surgeon he has performed more than 5,000 operations across all areas of urology, using open, endoscopic, laparoscopic and robotic approaches, including cancer surgery with bladder reconstruction.

He developed the bipolar endoscopic enucleation technique for prostatic adenoma (B-TUEP), including an ejaculation-sparing variant, and performs the minimally invasive i-Tind implant. He is a tutor at the Urology Specialisation School of the University of Milan.

Book a consultation Message us on WhatsApp

Education and career

  1. 1991Degree in Medicine and Surgery, University of Milan
  2. 1996Specialisation in Urology with honours, University of Milan
  3. 1997–2004Consultant urologist, San Gerardo Hospital, Monza, and San Paolo Hospital, Milan
  4. 2004–2022Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, deputy director of Urology
  5. 2022–2026ASST Santi Paolo e Carlo, deputy director of Urology and director of Urological Endoscopy
  6. Since 2026Director of the Urology Department, Fatebenefratelli e Oftalmico Hospital, Milan

Services

  • Urology consultationAt the practice
  • Minimally invasive treatment of benign prostatic hyperplasia (MIST, i-Tind implant)At partner hospitals
  • Bipolar endoscopic enucleation of the prostate (B-TUEP)At partner hospitals
  • Endoscopic treatment of benign prostatic hyperplasia, including large glandsAt partner hospitals
  • Robotic urological surgeryAt partner hospitals
  • Urological cancer surgery, including reconstructionAt partner hospitals
  • Targeted admissionsAt partner hospitals